Sign up to save your podcasts
Or
Share E121: Obinutuzumab in SLE-LN
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E121: Obinutuzumab in SLE-LN
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965
View all episodes
By Michael Putman
4.9
111111 ratings
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
322 Listeners
JAMA Clinical Reviews
505 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
Core IM | Internal Medicine Podcast
1,116 Listeners
Healio Rheuminations
120 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
362 Listeners
Freely Filtered, a NephJC Podcast
168 Listeners
ACR on Air
71 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
174 Listeners
Talking Rheumatology Spotlight
6 Listeners
ACR Journals On Air
20 Listeners